145P An engineered ligand-trap biologic targeting the CD47 signaling pathway for cancer treatment with superb efficacy and safety profiles

Z.S Juo,J-T Wang,C-L Tseng,H-F Teng,P-H Kuo,Y-C Cheng,Y-J Chen,Y-H Lu,T-K Shen,H-F Wang,P-L Tsai,Y-C Wu,C-H Ho,W-T Sun,Y-C Li,Y-H Lee

doi:10.1016/j.iotech.2023.100617

145P An engineered ligand-trap biologic targeting the CD47 signaling pathway for cancer treatment with superb efficacy and safety profiles

Z.S Juo, J-T Wang + Show 14 more

https://doi.org/10.1016/j.iotech.2023.100617

Copy DOI

Export

Save

Cite

Journal: Immuno-Oncology and Technology

Publication Date: Dec 1, 2023

#Safety Profiles #Pathway For Treatment #Efficacy Profiles #Pathway For Cancer Treatment #CD47 Signaling #Cancer Treatment #Signaling Pathway

Abstract
Full-Text
Similar Papers

Abstract

Listen

145P An engineered ligand-trap biologic targeting the CD47 signaling pathway for cancer treatment with superb efficacy and safety profiles

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Immuno-Oncology and Technology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

145P An engineered ligand-trap biologic targeting the CD47 signaling pathway for cancer treatment with superb efficacy and safety profiles